BIOMAT Database Logo BIOMAT Database Logo

Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction. 1985

R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane

Related Publications

R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.
June 1982, The Journal of clinical investigation,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
January 1981, The New England journal of medicine,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man.
May 1993, Clinical science (London, England : 1979),
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
[The effect of low dose aspirin on the platelet function in patients with acute myocardial infarction].
August 1993, Zhonghua nei ke za zhi,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
The effect of low dose aspirin on the platelet function in patients with acute myocardial infarction (AMI).
October 1995, Chinese medical journal,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
October 1994, Alimentary pharmacology & therapeutics,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
May 1981, Lancet (London, England),
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
April 2022, Clinical pharmacology and therapeutics,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
October 1990, Australian and New Zealand journal of medicine,
R De Caterina, and D Giannessi, and W Bernini, and P Gazzetti, and C Michelassi, and A L'Abbate, and L Donato, and P Patrignani, and P Filabozzi, and C Patrono
Corrigendum: Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
May 2023, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!